Comparison of Different Tumor Response Criteria in Patients with Hepatocellular Carcinoma After Systemic Therapy with the Multikinase Inhibitor Sorafenib
To access this article, please choose from the options below
Drs Bitzer and Horger contributed equally to this work.
PII: S1076-6332(10)00455-1
doi:10.1016/j.acra.2010.08.008
© 2011 AUR. Published by Elsevier Inc. All rights reserved.
